A novel monoclonal antibody against rat LFA-1: Blockade of LFA-1 and CD4 augments class II MHC expression on T cells

Hybridoma

Volumn 17, Issue 4, 1998, Pages 331-338

  Arnold, Paula Y ^a   Kearse, Kelly P ^a   Marinakis, Christopher A ^a   Mannie, Mark D ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; LEUKOCYTE ADHERENCE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE ACTIVATION;

ANIMALIA; MYCOBACTERIUM AVIUM COMPLEX (MAC);

EID: 0031713678     PISSN: 0272457X     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.1998.17.331     Document Type: Article

References (65)

1. Chien Y, and Davis MM: How αβ T-cell receptors see' peptide/MHC complexes. Immunol Today 1993;14:597-602.
2. Janeway CA: The T cell receptor as a mulicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation. Annu Rev Immunol 1992;10:645-674.
3. lck) that phosphorylates the CD3 complex. Proc Natl Acad Sci USA 1989;86:3277-3281.
4. Doyle C, and Strominger JL: Interactions between CD4 and class II MHC molecules mediates cell adhesion. Nature 1987;330: 256-259.
5. Dustin ML, and Springer TA: T cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 1989;341: 619-624.
6. Springer TA: Adhesion receptors of the immune system. Nature 1990;346:425-434.
7. Lub M, van Kooyk Y, and Figdor CG: Ins and outs of LFA-1. Immunol Today 1995;16:479-483.
8. Makgoba MW, Sanders ME, and Shaw S: The CD2/LFA-3 and LFA-1/ICAM-1 pathways: Relevance to T cell recognition. Immunol Today 1989;10:417-422.
9. Fine JS, and Kruisbeek AM: The role of LFA-1/ICAM-1 interactions during murine T lymphocyte development. J Immunol 1991;147:2852-2859.
10. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 1994;76:301-314.
11. van Noesel C, Miedema F, Brouwer M, de Rie MA, Arden LA, and van Lier RAW: Regulatory properties of LFA-1α and β chains in human T lymphocyte activation. Nature 1988;333:850-852.
12. Waldmann H, and Cobbold S: The use of monoclonal antibodies to achieve immunological tolerance. Immunol Today 1993;14: 247-251.
13. Herve P, Racadot E, Wendling D, Rumbach L, Tiberghien P, Cahn JY, Flesch M, and Wijdenes J: Use of monoclonal antibodies in vivo as a therapeutic strategy for alloimmune or autoimmune reactivity: The besancon experience. Immunol Rev 1992;129:31-55.
14. Qin S, Wise M, Cobbold SP, Leong L, Kong Y-CM, Parnes JR, and Waldmann H: Induction of tolerance in peripheral T cells with monoclonal antibodies. Eur J Immunol 1990;20:2737-2745.
15. Hutchings P, O'Reilly L, Parish NM, Waldmann H, and Cooke A: The use of non-depleting anti-CD4 monoclonal antibody to re-establish tolerance to β cells in NOD mice. Eur J Immunol 1992; 22:1913-1918.
16. Cobbold SP, Qin S, Leong LYW, Martin G, and Waldmann H: Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies. Immunol Rev 1992; 129:165-201.
17. Shizuru JA, Alters SE, and Fathman CG: Anti-CD4 monoclonal antibodies in therapy: Creation of nonclassical tolerance in the adult. Immunol Rev 1992;129:105:130.
18. Cobbold SP, Adams E, Marshall SE, Davies JD, and Waldmann H: Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8. Immunol Rev 1996; 149:5-33.
19. Cobbold SP, Martin G, and Waldmann H: The induction of skin graft tolerance in major histocompatibility complex-mismatched or primed recipients: Primed T cells can be tolerized in the periphery with anti-CD4 and anti-CD8 antibodies. Eur J Immunol 1990;20: 2747-2755.
20. Chen Z, Cobbold S, Metcalfe S, and Waldmann H: Tolerance in the mouse to major histocompatibility complex mismatched heart allografts, and to rat xenografts, using monoclonal antibodies to CD4 and CD8. Eur J Immunol 1992;22:805-810.
21. Sablinski T, Hancock WW, Tilney NL, and Kupiec-Weglinski JW: CD4 monoclonal antibodies in organ transplantation - a review of progress. Transplantation 1991;52:579-589.
22. Davies JD, Martin G, Phillips J, Marshall SE, Cobbold SP, and Waldmann H: T cell regulation in adult transplantation tolerance. J Immunol 1996;157:529-533.
23. Qin S, Cobbold SP, Pope H, Elliot J, Kioussis D, Davies J, and Waldmann H: "Infectious" transplantation tolerance. Science 1993; 259:974-977.
24. Bushell A, Morris PJ, and Wood KJ: Transplantation tolerance induced by antigen pretreatment and depleting anti-CD4 antibody depends on CD4+ T cell regulation during the induction phase of the response. Eur J Immunol 1995;25:2643-2649.
25. Hutchings PR, Cooke A, Dawe K, Waldmann H, and Roitt IM: Active suppression induced by anti-CD4. Eur J Immunol 1993;23: 965-968.
26. Scully R, Qin S, Cobbold S, and Waldmann H: Mechanisms in CD4 antibody-mediated transplantation tolerance: Kinetics of induction, antigen dependency and role of regulatory T cells. Eur J Immunol 1994;24:2383-2392.
27. Yin D and Fathman CG: CD4-positive suppressor cells block allotransplant rejection. J Immunol 1995;154:6339-6345.
28. Kawai K, Kobayashi Y, Shiratori M, Sobue G, Tamatani T, Miyasaka M, and Yoshikai Y: Intrathecal administration of antibodies against LFA-1 and against ICAM-1 suppresses experimental allergic encephalomyelitis in rats. Cell Immunol 1996;171:262-268.
29. Kobayashi Y, Kawai K, Honda H, Tomida S, Niimi N, Tamatani T, Miyasaka M, and Yoshikai Y: Antibodies against leukocyte function-associated antigen-1 and against intercellular adhesion molecule-1 together suppress the progression of experimental allergic encephalomyelitis. Cell Immunol 1995;164:295-305.
30. Gordon EJ, Myers KJ, Dougherty JP, Rosen H, and Ron Y: Both anti-CD11a (LFA-1) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis. J Neuroimmunol 1995;62:153-160.
31. Isobe M, Suzuki J, Yamazaki S, and Sekiguchi M: Acceptance of primary skin graft after treatment with anti-intercellular adhesion molecule-1 and anti-leukocyte function-associated antigen-1 monoclonal antibodies in mice. Transplantation 1996;62:411-413.
32. Talento A, Nguyen M, Blake T, Sirotina A, Fioravanti C, Burkholder D, Gibson R, Sigal NH, Springer MS, and Koo GC: A single administration of LFA-1 antibody confers prolonged allograft survival. Transplantation 1993;55:418-422.
33. Nakakura EK, Shorthouse RA, Zheng B, McCabe SM, Jardieu PM, and Morris RE: Long-term survival of solid organ allografts by brief anti-lymphocyte function-associated antigen-1 monoclonal antibody monotherapy. Transplantation 1996;62:547-552.
34. van Dijken PJ, Ghayur T, Mauch P, Down J, Burakoff SJ, and Ferrara JLM: Evidence that anti-LFA-1 in vivo improves engraftment and survival after allogeneic bone marrow transplantation. Transplantation 1990;49:882-886.
35. Isobe M, and Ihara A: Tolerance induction against cardiac allograft by anti-ICAM-1 and anti-LFA-1 treatment: T cells respond to in vitro allostimulation. Transplant Proc 1993;25:1079-1080.
36. Bashuda H, Seino K, Ra C, Yagita H, and Okumura K: Lack of cognate help by CD4+ T cells and anergy of CD8+ T cells are the principal mechanisms for anti-leukocyte function-associated antigen-1/intercellular adhesion molecule-1-induced allograft tolerance. Transplantation 1997;63:113-118.
37. Willenborg DO, Staykova MA, and Miyasaka M: Short term treatment with soluble neuroantigen and anti-CD11a (LFA-1) protects rats against autoimmune encephalomyelitis: Treatment abrogates autoimmune disease but not autoimmunity. J Immunol 1996;157: 1973-1980.
38. Jendrisak M, Jendrisak G, Gamero J, and Mohanakumar T: Prolongation of murine cardiac allograft survival with monoclonal antibodies to LFA-1, ICAM-1, and CD4. Transplant Proc 1993;25: 825-827.
39. Jendrisak G, Gamero J, Mohanakumar T, and Jendrisak M: Clonal anergy induction by monoclonal antibodies to CD4, LFA-1, and ICAM-1. Transplant Proc 1993;25:828-830.
40. Mannie MD, Morrison-Plummer J, Torres-Garcia B, Hannaway C, Jones C, and Smith AM: Parallel costimulatory pathways promote myelin basic protein-stimulated proliferation of encephalitogenic rat T cells. Cell Immunol 1994;153:312-328.
41. Mannie MD, Rendall SK, Arnold PY, Nardella JP, and White GA: Anergy-associated T cell antigen presentation: A mechanism of infectious tolerance in experimental autoimmune encephalomyelitis. J Immunol 1996;157:1062-1070.
42. Bellini T, Rippa M, Matteuzzi M, and Dallochio F: A rapid method for purification of myelin basic protein. J Neurochem 1986;46: 1644-1646.
43. Webb M, Mason D, and Williams AF: Inhibition of mixed lymphocyte response by monoclonal antibody specific for a rat T lymphocyte subset. Nature 1979;282:841-843.
44. Clark SJ, Law DA, Paterson DJ, Puklavec M, and Williams AF: Activation of rat T lymphocytes by anti-CD2 monoclonal antibodies. J Exp Med 1988;167:1861-1872.
45. Mannie MD, Paterson PY, U'Prichard DC, and Thomas DW: Clonotypic heterogeneity of Lewis rat T cells specific for the encephalitogenic 68-86 region of myelin basic protein. Cell Immunol 1989;122:534-547.
46. Mannie MD, Rosser JM, and White GA: Autologous rat myelin basic protein is a partial agonist that is converted to a full antagonist upon blockade of CD4: Evidence for the integration of efficacious and nonefficacious signals during T cell antigen recognition. J Immunol 1995;154:2642-2654.
47. Arnold PY, Davidian DK, and Mannie MD: Antigen presentation by T cells: T cell receptor ligation promotes antigen acquisition from professional antigen presenting cells. Eur J Immunol 1997; 27:3198-3205.
48. Johnson BD, Nardella JP, McConnell TJ, and Mannie MD: Acquired resistance to experimental autoimmune encephalomyelitis is independent of Vβ usage. Cell Immunol 1997;179:55-65.
49. O'Farrell PZ, Goodman HM, and O'Farrell PH: High resolution two-dimensional electrophoresis of basic as well as acidic proteins. Cell 1977;12:1133-1141.
50. Baars PA, Maurice MM, Rep M, Hooibrink B, and van Lier RA: Heterogeneity of the circulating human CD4+ T cell population. Further evidence that the CD4+CD45RA-CD27-T cell subset contains specialized primed T cells. J Immunol 1995;154:17-25.
51. Hoshino T, Yomada A, Honda J, Imai Y, Nakao M, Inoue M, Sagawa K, Yokoyama MM, Oizumi K, and Itoh K: Tissue-specific distribution and age-dependent increase of human CD11b+ T cells. J Immunol 1993;151:2237-2246.
52. + T cells from HIV-infected subjects. Clin Exp Immunol 1995;100:425-433.
53. Muto S, Vetvicka V, and Ross GD: CR3 (CD11b/CD18) expressed by cytotoxic T cells and natural killer cells is upregulated in a manner similar to neutrophil CR3 following stimulation with various activating agents. J Clin Immunol 1993;13:175-184.
54. + T cells in vivo. J Immunol 1995;154:5684-5693.
55. Madrenas J, Chau LA, Smith J, Bluestone JA, and Germain RN: The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands. J Exp Med 1997;185:219-229.
56. Tsitoura DC, Holler W, Cerwenka A, Gelder CM, and Lamb JR: Induction of energy in human T helper 0 cells by stimulation with altered T cell antigen receptor ligands. J Immunol 1996;156:2801-2808.
57. + T cell activation. Int Immunol 1996;8:267-274.
58. lck/CD4-dependent down regulation of LFA-1-mediated T cell adhesion. J Immunol 1996;157: 4844-4854.
59. Eberle M, Traynor-Kaplan AE, Sklar LA, and Norgauer J: Is there a relationship between phosphatidylinositol trisphosphate and F-actin polymerization in human neutrophils? J Biol Chem 1990;265:16725-16728.
60. Guinebault C, Payrastre B, Racaud-Sultan C, Mazarguil H, Breton M, Mauco G, Plantavid M, and Chap H: Integrin-dependent translocation of phosphoinositide 3-kinase to the cytoskeleton of thrombin-activated platelets involves specific interactions of p85α with actin filaments and focal adhesion kinase. J Cell Biol 1995;129: 831-842.
61. Shibasaki F, Fukami K, Fukui Y, and Takenawa T: Phosphatidylinositol 3-kinase binds to α-actinin through the p85 subunit. Biochem J 1994;302:551-557.
62. Wymann M, and Arcaro A: Platelet-derived growth factor-induced phosphatidylinositol 3-kinase activation mediates actin rearrangements in fibroblasts. Biochem J 1994;298:517-520.
63. Reizis B, Schramm C, Cohne IR, and Mor F: Expression of major histocompatibility complex class II molecules in rat T cells. Eur J Immunol 1994;24:2796-2802.
64. Lorber MI, Loken MR, Stall AM, and Fitch FW: I-A antigens on cloned alloreactive murine T lymphocytes are acquired passively. J Immunol 1982;128:2798-2803.
65. Sharrow SO, Ozato K, and Sachs DH: Phenotypic expression of I-A and I-E/c subregion determinants on murine thymocytes. J Immunol 1980;125:2263-2268.